A patient exhibits tremors and rigidity characteristic of Parkinson's disease. What process fails to prevent cellular dysfunction when alpha-synuclein aggregates accumulate in dopaminergic neurons?

💡 Explanation

Parkinson's disease involves the accumulation of alpha-synuclein aggregates, leading to cellular dysfunction. Impaired proteasomal protein degradation prevents the removal of these toxic aggregates, because the proteasome is crucial for degrading misfolded proteins. Therefore, the dysfunction arises from the aggregates persisting, rather than other cellular processes being directly compromised.

• Which consequence results when damage reduces gastric parietal cell mass?
• A patient with severe burns receives a lipophilic drug. If edema significantly increases their extracellular fluid volume, which consequence follows?
• If a patient with a genetic defect lacks functional B-cells, which immunological consequence primarily limits their defense against encapsulated bacteria?
• If a genetically modified T-cell with a chimeric antigen receptor (CAR) encounters its target cancer cell, which consequence follows regarding local inflammation?
• A catheterized patient develops a persistent urinary tract infection despite antibiotic treatment. Which mechanism explains why the *E. coli* biofilm exhibits resistance when planktonic bacteria are susceptible?
• Why does neuronal function decline during neurodegenerative diseases featuring protein aggregates like amyloid plaques or Lewy bodies?